Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2026-01-08 @ 6:35 PM
Study NCT ID:
NCT02227433
Status:
COMPLETED
Last Update Posted:
2020-12-22
First Post:
2014-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Brentuximab Vedotin in the Elderly Hodgkin Lymphoma Patients at First Relapse or With Primary Refractory Disease.
Sponsor:
Fondazione Italiana Linfomi - ETS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02-04
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-11
First Submit QC Date:
None
Study First Post Date:
2014-08-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-21
Last Update Post Date:
2020-12-22
Last Update Post Date Type:
ACTUAL